Healthcare access is widening across Asia, the Middle East and Latin America, and respiratory care is expanding with it. That progress is opening room for the Oxygen Therapy Equipment Market, valued at US$ 3.89 Billion in 2025 and forecast to touch US$ 7.10 Billion by 2034. Growth of 6.91% CAGR is expected between 2026 and 2034.
What Is Oxygen Therapy Equipment?
Oxygen therapy equipment includes the devices that store,
generate and deliver supplemental oxygen to patients whose lungs cannot supply
enough on their own. It covers concentrators, cylinders, liquid oxygen systems
and the masks, cannulas and regulators that connect them to the patient. The
oxygen therapy equipment market serves hospitals, surgical centres and homes
alike.
What Is Driving Demand in the Oxygen Therapy Equipment
Market?
So, what is pushing demand higher? Start with the clinical
reality. Chronic obstructive pulmonary disease, asthma and a long tail of other
respiratory conditions keep adding patients who need supplemental oxygen,
sometimes for a few weeks and often for life. Ageing populations in Japan,
Europe and North America amplify that need, because lung function declines and
comorbidities accumulate with age. Every new diagnosis widens the base of the
oxygen therapy equipment market.
Request a Sample Copy of the Report: https://www.theinsightpartners.com/sample/TIPMD00002254
Beyond that, the care model itself is changing. Health
systems under budget pressure want shorter hospital stays, and patients prefer
to recover at home. Lightweight concentrators and compact delivery devices make
that possible, giving users a mobility, that bulky cylinders never could. This
is not just a trend, it is a structural shift, and it is reshaping purchasing
decisions across the oxygen therapy equipment market.
Recent respiratory crises also left a lasting mark.
Hospitals and governments learnt how quickly oxygen supply can become a
bottleneck, and many have since strengthened stockpiles, procurement frameworks
and local supply chains. Equipment once treated as a routine commodity is now
viewed as critical infrastructure.
Technology adds further momentum. Pulse-dose delivery,
smarter flow control, longer battery life and quieter operation improve
adherence, which in turn improves outcomes. Manufacturers that pair clinical
reliability with everyday usability are the ones gaining share in the oxygen
therapy equipment market.
Segmentation Overview
By Product: The market spans Oxygen Concentrators, Oxygen
Delivery Devices, Liquid Oxygen Devices and Oxygen Cylinders. Oxygen
concentrators draw in ambient air and produce oxygen on demand, so they suit
long-term home users who want freedom from refills. Oxygen delivery devices,
including masks and cannulas, form the final link between source and patient.
Liquid oxygen devices pack more oxygen into a lighter footprint for active
users, while oxygen cylinders remain the dependable backup in emergencies and
in facilities with unreliable power.
By Application: COPD, Respiratory Diseases, Asthma and
Others make up the application mix. COPD anchors long-term oxygen demand, since
progressive airflow limitation often calls for continuous supplementation. The
wider respiratory diseases segment covers conditions such as pneumonia and
pulmonary fibrosis, where oxygen therapy is central to stabilisation. Asthma
drives more intermittent use during acute episodes, and the Others segment
captures post-surgical and critical care needs.
By End User: Hospitals, Ambulatory Surgical Centers and
Homecare Settings define the buyer base. Hospitals remain a major procurement
channel, supported by central oxygen systems and high patient volumes.
Ambulatory surgical centres need compact, flexible equipment for short
procedures and recovery. Homecare settings are the most dynamic frontier, as
patients and caregivers adopt portable systems for daily management.
Key Market Players
- Koninklijke
Philips N.V
- Smiths
Medical (A Division of Smiths Group PLC)
- Teleflex
Incorporated
- Linde
Healthcare
- Fisher
& Paykel Healthcare Limited.
- Invacare
Corporation
- Inogen
- Sunset
Healthcare Solutions Inc
- Care
Enterprise Co., Ltd
- Salter
Labs
Koninklijke Philips N.V and Inogen are closely associated
with concentrator innovation, while Linde Healthcare brings gas supply scale to
hospitals and homecare providers. Fisher & Paykel Healthcare Limited and
Teleflex Incorporated are recognised for respiratory delivery devices, and
Smiths Medical, Salter Labs and Invacare Corporation add breadth across patient
interfaces and home equipment. Competition in the oxygen therapy equipment
market centres on portability, reliability and service networks.
Sustainability and Innovation Trends
Sustainability is entering the conversation. Concentrators
generate oxygen from air, which cuts the transport emissions and cylinder
logistics tied to conventional supply. Manufacturers are working on energy-efficient
compressors, recyclable materials and longer-lasting components, while
connected devices with remote monitoring let clinicians adjust therapy without
unnecessary visits. These advances lower both the environmental footprint and
the running cost of care, and they are becoming a genuine selling point.
Regional Outlook
North America benefits from high awareness of respiratory
disease, established reimbursement for home oxygen and a strong base of device
manufacturers. Europe pairs an ageing population with well-developed public
healthcare, which supports steady adoption of homecare oxygen solutions. Asia
Pacific offers considerable room to grow, as expanding healthcare access,
rising respiratory disease awareness and large patient populations lift demand
across the oxygen therapy equipment market. South and Central America is
building capacity gradually, with hospitals upgrading oxygen infrastructure and
homecare options slowly gaining ground.
About The Insight Partners
The Insight Partners is among the leading market research
and consulting firms in the world. We take pride in delivering exclusive
reports along with sophisticated strategic and tactical insights into the
industry. Reports are generated through a combination of primary and secondary
research, solely aimed at giving our clientele a knowledge-based insight into
the market and domain. This is done to assist clients in making wiser business
decisions. A holistic perspective in every study undertaken forms an integral
part of our research methodology and makes the report unique and reliable.
Contact Us:
If you have any queries about this report or if you would
like further information, please contact us:
Phone: +1-646-491-9876
E-mail: sales@theinsightpartners.com
Also Available in: Korean | German | Japanese | French | Chinese | Italian | Spanish
No comments:
Post a Comment